154 related articles for article (PubMed ID: 8501156)
1. Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism.
Lieverse RJ; Jansen JB; van de Zwan A; Samson L; Masclee AA; Rovati LC; Lamers CB
J Clin Endocrinol Metab; 1993 Jun; 76(6):1495-8. PubMed ID: 8501156
[TBL] [Abstract][Full Text] [Related]
2. Bombesin reduces food intake after a preload in man by a cholecystokinin-independent mechanism.
Lieverse RJ; Jansen JB; Masclee AA; Lamers CB
Clin Sci (Lond); 1993 Sep; 85(3):277-80. PubMed ID: 8403798
[TBL] [Abstract][Full Text] [Related]
3. Significant satiety effect of bombesin in lean but not in obese subjects.
Lieverse RJ; Jansen JB; Masclee AA; Lamers CB
Int J Obes Relat Metab Disord; 1994 Aug; 18(8):579-83. PubMed ID: 7951480
[TBL] [Abstract][Full Text] [Related]
4. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
[TBL] [Abstract][Full Text] [Related]
5. Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women.
Lieverse RJ; Masclee AA; Jansen JB; Rovati LC; Lamers CB
Biol Psychiatry; 1995 Mar; 37(5):331-5. PubMed ID: 7748985
[TBL] [Abstract][Full Text] [Related]
6. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
Jansen JB; Jebbink MC; Douglas BR; Lamers CB
Eur J Clin Pharmacol; 1990; 38(4):367-70. PubMed ID: 2344859
[TBL] [Abstract][Full Text] [Related]
7. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans.
Drewe J; Gadient A; Rovati LC; Beglinger C
Gastroenterology; 1992 May; 102(5):1654-9. PubMed ID: 1568575
[TBL] [Abstract][Full Text] [Related]
8. The effects of loxiglumide on food intake in normal weight volunteers.
French SJ; Bergin A; Sepple CP; Read NW; Rovati L
Int J Obes Relat Metab Disord; 1994 Nov; 18(11):738-41. PubMed ID: 7866473
[TBL] [Abstract][Full Text] [Related]
9. Obese women are less sensitive for the satiety effects of bombesin than lean women.
Lieverse RJ; Masclee AA; Jansen JB; Lam WF; Lamers CB
Eur J Clin Nutr; 1998 Mar; 52(3):207-12. PubMed ID: 9537307
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
Hayes MR; Savastano DM; Covasa M
Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats.
Meereis-Schwanke K; Klonowski-Stumpe H; Herberg L; Niederau C
Peptides; 1998; 19(2):291-9. PubMed ID: 9493861
[TBL] [Abstract][Full Text] [Related]
13. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man.
Jebbink MC; Jansen JB; Mooy DM; Rovati LC; Lamers CB
Regul Pept; 1991 Feb; 32(3):361-8. PubMed ID: 1714084
[TBL] [Abstract][Full Text] [Related]
14. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging.
MacIntosh CG; Morley JE; Wishart J; Morris H; Jansen JB; Horowitz M; Chapman IM
J Clin Endocrinol Metab; 2001 Dec; 86(12):5830-7. PubMed ID: 11739447
[TBL] [Abstract][Full Text] [Related]
15. Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans.
Gutzwiller JP; Drewe J; Ketterer S; Hildebrand P; Krautheim A; Beglinger C
Am J Physiol Regul Integr Comp Physiol; 2000 Jul; 279(1):R189-95. PubMed ID: 10896881
[TBL] [Abstract][Full Text] [Related]
16. Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin.
Covasa M; Ritter RC
Peptides; 1998; 19(8):1407-15. PubMed ID: 9809656
[TBL] [Abstract][Full Text] [Related]
17. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
[TBL] [Abstract][Full Text] [Related]
18. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.
de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB
Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin and bombesin act independently to decrease food intake in the rat.
Stein LJ; Woods SC
Peptides; 1981; 2(4):431-6. PubMed ID: 6276871
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
Jebbink MC; Jansen JB; Masclee AA; Lamers CB
Br J Clin Pharmacol; 1990 Jun; 29(6):770-3. PubMed ID: 2378793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
